These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25260618

  • 1. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.
    Wilson K, Guggilam A, West TA, Zhang X, Trask AJ, Cismowski MJ, de Tombe P, Sadayappan S, Lucchesi PA.
    Am J Physiol Heart Circ Physiol; 2014 Dec 01; 307(11):H1605-17. PubMed ID: 25260618
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S, Cheng HJ, Tachibana H, Little WC, Cheng CP.
    Am J Physiol Heart Circ Physiol; 2011 Aug 01; 301(2):H488-96. PubMed ID: 21572004
    [Abstract] [Full Text] [Related]

  • 3. Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.
    Gladden JD, Zelickson BR, Guichard JL, Ahmed MI, Yancey DM, Ballinger S, Shanmugam M, Babu GJ, Johnson MS, Darley-Usmar V, Dell'Italia LJ.
    Am J Physiol Heart Circ Physiol; 2013 Nov 15; 305(10):H1440-50. PubMed ID: 24014679
    [Abstract] [Full Text] [Related]

  • 4. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V, Kramer F, Golz S, Knorr A, Andersson KB, Christensen G.
    J Appl Physiol (1985); 2013 Nov 15; 115(10):1572-80. PubMed ID: 24072410
    [Abstract] [Full Text] [Related]

  • 5. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP, Pagel PS, Tessmer JP, Warltier DC.
    J Cardiovasc Pharmacol; 1995 Aug 15; 26(2):179-88. PubMed ID: 7475041
    [Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.
    Guggilam A, Hutchinson KR, West TA, Kelly AP, Galantowicz ML, Davidoff AJ, Sadayappan S, Lucchesi PA.
    J Mol Cell Cardiol; 2013 Apr 15; 57():47-58. PubMed ID: 23220155
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    Anesthesiology; 1994 Oct 15; 81(4):974-87. PubMed ID: 7943849
    [Abstract] [Full Text] [Related]

  • 8. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.
    Hutchinson KR, Guggilam A, Cismowski MJ, Galantowicz ML, West TA, Stewart JA, Zhang X, Lord KC, Lucchesi PA.
    J Appl Physiol (1985); 2011 Dec 15; 111(6):1778-88. PubMed ID: 21885799
    [Abstract] [Full Text] [Related]

  • 9. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ.
    Circ Res; 1995 Jul 15; 77(1):107-13. PubMed ID: 7788868
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS, Hettrick DA, Warltier DC.
    Basic Res Cardiol; 1996 Jul 15; 91(4):296-307. PubMed ID: 8874779
    [Abstract] [Full Text] [Related]

  • 11. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM, Andreou C, Conrad CH, Colucci WS.
    Circulation; 2007 Mar 13; 115(10):1218-24. PubMed ID: 17339544
    [Abstract] [Full Text] [Related]

  • 12. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
    Lunghetti S, Palmerini E, Urselli R, Maffei S, Guarino E, Focardi M, Mondillo S, Favilli R.
    Cardiol J; 2011 Mar 13; 18(5):532-7. PubMed ID: 21947989
    [Abstract] [Full Text] [Related]

  • 13. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.
    Tachibana H, Cheng HJ, Ukai T, Igawa A, Zhang ZS, Little WC, Cheng CP.
    Am J Physiol Heart Circ Physiol; 2005 Feb 13; 288(2):H914-22. PubMed ID: 15486041
    [Abstract] [Full Text] [Related]

  • 14. Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart.
    Feridooni HA, MacDonald JK, Ghimire A, Pyle WG, Howlett SE.
    Am J Physiol Heart Circ Physiol; 2017 Jan 01; 312(1):H46-H59. PubMed ID: 27793852
    [Abstract] [Full Text] [Related]

  • 15. Calcium sensitisation impairs diastolic relaxation in post-ischaemic myocardium: implications for the use of Ca(2+) sensitising inotropes after cardiac surgery.
    Choi YH, Cowan DB, Wahlers TC, Hetzer R, Del Nido PJ, Stamm C.
    Eur J Cardiothorac Surg; 2010 Feb 01; 37(2):376-83. PubMed ID: 19616444
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS, McGough MF, Hettrick DA, Lowe D, Tessmer JP, Jamali IN, Warltier DC.
    J Cardiovasc Pharmacol; 1997 May 01; 29(5):563-73. PubMed ID: 9213196
    [Abstract] [Full Text] [Related]

  • 17. A Review on Role of the Calcium Sensitive Inotropic Agent, Levosimendan and Its Metabolites.
    Asif M.
    Mini Rev Med Chem; 2018 May 01; 18(16):1354-1362. PubMed ID: 27594341
    [Abstract] [Full Text] [Related]

  • 18. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    J Pharmacol Exp Ther; 1995 Oct 01; 275(1):127-35. PubMed ID: 7562540
    [Abstract] [Full Text] [Related]

  • 19. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B, Häggmark S, Svenmarker S, Johansson G, Gupta A, Tydén H, Wouters P, Haney M.
    J Cardiovasc Pharmacol Ther; 2016 Sep 01; 21(5):495-503. PubMed ID: 26837238
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of SR33805 in failing myocardium.
    Ait Mou Y, Toth A, Cassan C, Czuriga D, de Tombe PP, Papp Z, Lacampagne A, Cazorla O.
    Cardiovasc Res; 2011 Aug 01; 91(3):412-9. PubMed ID: 21467075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.